![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Dr. Parvinder Punia, Senior regulatory expert will present “European experience of harmonising the pharmaceutical market” at Moscow conference on February 10th 2015
Cambridge, UK, 2nd February 2015 – ELC Group, one of the fastest-growing providers of regulatory affairs, today announces that its Senior Regulatory Affairs Manager Dr Parvinder Punia will be an invited speaker at the 3rd Annual Regulatory & Legal Affairs in Russia conference being held at the Marriott Grand Hotel in Moscow from February 10th – 12th 2015.
Dr. Punia will be speaking on the opening day of the conference, Tuesday 10th February in the afternoon, on the topic of “European experience of harmonising the pharmaceutical market”, which forms part of the special Focus Day “Circulation of drugs within the customs Union and Eurasian Economic Union”. Dr. Punia was invited to give the keynote presentation due to the Russia and CIS program of harmonisation now taking place, and to provide authoritative insight on the lessons learned from the EU, both positive and negative. Last year, ELC Group announced the opening of a regional base in Russia following a year of record growth, and the appointment of Inna Demidova as a Senior Regulatory Affairs Expert for Russia and the Commonwealth of Independent States (CIS).
Regulatory & Legal Affairs in Russia 2015 is a three-day conference attended by more than 150 industry professionals, including government representatives, international specialists, leading physicians and pharmaceutical associations. The pre-conference focus days and main two-day conference will be addressed by more than 50 expert speakers from across pharmaceutical regulatory spectrum.
With a scientific background, Dr. Punia has nine years’ regulatory experience, which includes 3 years from within two EU Health Agencies (Portugal and MHRA in the UK). She has represented the UK agency at the EMEA level. Her key expertise is in strategy, budgeting, preparation, co-ordination and review of a variety of scientific and regulatory documents for European and experience in non-European countries. Dr. Punia has an extensive knowledge of the development cycle and internal knowledge of the EU and other regulated region procedures and has worked in a business development capacity.
For more information about the conference and to register to attend, please visit: http://www.pharma-regulatory-affairs.com/
-end-
Note to editors:
If you would be interested in scheduling a briefing with ELC Group, please contact Nicky Denovan at nicky[at]evokedset[dot]com.
Press contacts:
Akhil Jain
ELC Group
ajain [at] elc-group [dot] com
Phone: +420 22 491 00 00
Nicky Denovan
EvokedSet PR
nicky[at] evokedset [dot] com
Phone: +44 (0)7747 017654
About ELC Group:
ELC GROUP is a fully-fledged global regulatory partner, working with major pharmaceutical stakeholders for over a decade.
From Concept to Commercialisation is one of the key partnership areas in which ELC GROUP is creating its fast-growing success. From the development stage through to the implementation of clinical trials, completion of product registration, and successful marketing of the product, ELC GROUP aligns itself as a strategic partner to help pharmaceutical companies achieve their healthcare goals.
ELC GROUP’s worldwide network of professionals spans all major Regulatory Affairs services across the key healthcare vertical markets of Pharmaceuticals, Biotech, Clinical, Consumer Healthcare, Medical Devices, Nutraceuticals and Veterinary. The team ranges from former FDA investigators to individuals with over 30 years of industry experience and broad capabilities, including in the areas of integrated advanced technologies, Regulatory Affairs consulting and commercialisation services.
ELC GROUP works with equal success in partnership with large multi-nationals, small enterprises and start-ups, biotechs, CROs and device manufacturers.
